Skip to content

The effects of novel chocolate on postprandial blood glucose level in healthy adults

The effects of novel chocolate on postprandial blood glucose level in healthy adults - The effects of dietary novel chocolate on postprandial blood glucose

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034606
Enrollment
12
Registered
2018-12-24
Start date
2018-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Single dose administration of 65 g of the novel chocolate in intervention period Single dose administration of 65 g of the control chocolate in control period Single dose administration of 19.2 g of s

Sponsors

Suzuka University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study 2) Those who belong to a particular university. 3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test 4) Subjects with systolic blood pressure under 140 mmHg and diastolic blood pressure under 90 mm Hg 5) Subjects with BMI above 18.5 kg/ m2-under 30 kg/ m2 6) Females who have a regular menstrual cycle, which is 25 to 38 days, and at the first test, who are from 14 days after the start of their menstruation to the next menstruation. 7) Non-smokers

Exclusion criteria

Exclusion criteria: 1) Those who administer ''Food for Specified Health Use'', ''Foods with Function Claims'' or medicine to have effects on blood glucose metabolism. 2) Patients with diseases undergoing treatments or with medical history of severe diseases. 3) Patients who have severe diseases: diabetes, liver disease, kidney disease, heart disease (or persons who have history of these diseases). 4) Those who may suffer from allergy by administering milk, soybean, or cacao mass (chocolate). 5) Subjects who are in pregnancy, lactation. 6) Those who were included other clinical trials within one month before giving written informed consent, or during this study. 7) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator or examination doctor.

Design outcomes

Primary

MeasureTime frame
Blood glucose level, the blood glucose areas under the curve (AUC), the maximum blood glucose level(Cmax) , and time to reach Cmax(Tmax)

Countries

Japan

Contacts

Public ContactMidori Natsume

Meiji Co., Ltd. Group2, Food Science & Technology Research Laboratories, R&D Division

midori.natsume@meiji.com042-632-5850

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026